戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 363作成日:2026年10月23日

2,4-Dichloropyridine → N-(4-chloro-2-pyridinyl)-1,3-oxazol-2-amine

https://huagongshe.com/ja/reaction/363

反応式

関与物質

役割名称HCID仕込み量
反応物2,4-DichloropyridineHCID 33515—
反応物2-AminooxazoleHCID 558521—
試薬Phenolate SodiumHCID 4445035—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒1,4-DioxaneHCID 31275—
生成物N-(4-chloro-2-pyridinyl)-1,3-oxazol-2-amineHCID 1300162603.03%

反応条件

温度130 °C

反応手順

To a microwave vial containing 2,4-dichloropyridine (0.109 mL, 1.01 mmol), sodium phenolate (177 mg, 1.52 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (11.60 mg, 0.01 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (17.59 mg, 0.03 mmol) (Xantphos), was added degassed dioxane (4 mL) and the mixture allowed to stir under nitrogen atmosphere for 5 min. To this solution was added oxazol-2-amine (94 mg, 1.11 mmol) and the reaction mixture was heated to 130 °C for 30 min under microwave irradiation. **Apparently no 2-aminooxazole remains by proton NMR of crude reaction mixture upon removal of dioxane, however it's presence was observed by LCMS of the crude reaction mixture (see attached). It is possible that the presence of impurities/solvent etc. have shifted the resonances slightly for this starting material in** **1** **H NMR.** The crude product was purified by reverse-phase flash chromatography on C-18 modified silica, elution gradient 0 to 100% MeCN in water. Pure fractions were evaporated to dryness to afford N-(4-chloropyridin-2-yl)oxazol-2-amine (6.00 mg, 3.03 %) as a pale yellow dry film. 3 % of the required product was isolated and this sample was impure. Microwave heating has no positive effect under these reaction conditions. Upon submission of a crude sample of the reaction mixture to both starting materials were observed. Conclusion: 3% of impure material isolated, look for alternative conditions.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-db4d850d1c594ca584a3d40b664f692e
出典メモ750 AstraZeneca ELN dataset